ホーム › 潰瘍性大腸炎 › コロラド州 › Colorado Springs
Colorado Springs、COにおける潰瘍性大腸炎の臨床試験
Colorado Springsとその周辺地域（約30マイル以内）の拠点で、潰瘍性大腸炎に関する14件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
被験者募集中第2相
- Peak Gastroenterology Associates - Colorado Springs - North Cascade Avenue /ID# 280507, Colorado Springs
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
被験者募集中第2相
- Peak Gastroenterology Associates, Colorado Springs
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
被験者募集中第4相
- Peak Gastroenterology Associates, Colorado Springs
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
被験者募集中第2相
- Site 033, Colorado Springs
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
被験者募集中第2相
- Peak Gastroenterology Associates, Colorado Springs
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
被験者募集中第2相
- Peak Gastroenterology Associates ( Site 1052), Colorado Springs
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
被験者募集中第3相
- Peak Gastroenterology Associates, Colorado Springs
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
被験者募集中第2相
- Peak Gastroenterology Associates, Colorado Springs
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
被験者募集中第2相
- Peak Gastroenterology Associates, Colorado Springs
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
被験者募集中第3相
- Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039, Colorado Springs
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
被験者募集中第3相
- Peak Gastroenterology Associates, Colorado Springs
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
被験者募集中第2相
- Peak Gastroenterology Associates, Colorado Springs
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
被験者募集中第3相
- Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039, Colorado Springs
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
被験者募集中第2相
- Mirador Therapeutics Selected Site, Colorado Springs
他の都市における潰瘍性大腸炎の試験
- New York City, NY23件の研究
- Orlando, FL22件の研究
- Miami, FL21件の研究
- Houston, TX17件の研究
- San Antonio, TX16件の研究
- Tyler, TX15件の研究
- Tacoma, WA15件の研究
- Chicago, IL15件の研究
- San Diego, CA15件の研究
- St. Louis, MO13件の研究
- Los Angeles, CA13件の研究
- Washington, DC12件の研究
Colorado Springsにおける他の研究
- クローン病13件の研究
- 前立腺がん12件の研究
- 非小細胞肺癌11件の研究
- 肺がん8件の研究
- 乳がん7件の研究
- 喘息6件の研究
- 結腸癌6件の研究
- 大腸癌6件の研究
- 直腸がん4件の研究
- 過眠症4件の研究
- 炎症性腸疾患4件の研究
- 頭頸部扁平上皮癌4件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。